Betterlife Pharma Inc (BETR) Annual Income Statement

Annual · GAAP · USD millions
Access BETR quarterly income statements →
The data below summarizes Betterlife Pharma Inc's income statement results from Jan 31 2022 to Jan 31 2026, enabling period-by-period comparison of operating performance.
Annual Report, GAAP in USD millions
ITEM
(Jan 31 2026)
2026
(Dec 31 2025) (Dec 31 2024) (Dec 31 2023) (Jan 31 2022)
Revenues
Interest Income, Operating0.00
Other Income0.00
Total Interest Income0.12
Interest Expense, Debt0.00
Net Interest (-)Expense / Income-0.12
Net Interest Income0.00
Total Net Interest Income0.00
Revenue From Contract With Customer Including Assessed Tax0.00
Loss / Gain on Investment0.00
Other Non-Interest Income0.00
Total Non-interest Income-0.15
Total Revenues-0.15
Costs & Expenses
Salaries & employee benefits, SGA0.16
Restructuring, Accretion & impairment charges0.00
Depreciation & Amortization0.00
Loan Processing Fee0.00
Other loss /-income1.00
Total Operating Expenses1.16
Total Costs & Expenses1.28
Income & Taxes
Income /-loss before income taxes-1.16
Income taxes expenses/-benefit0.00
Income after income taxes-1.16
Net income/-loss of other equity0.00
Income /-loss after income taxes-1.16
Profit Loss Attributable To Noncontrolling Interests-0.01
Net Income/-loss-1.16
Non-controlling interests-0.01
Income/-loss to shareholder-1.15
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)145.88
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)145.88
4 historic quarters locked

Sign in to unlock the full Betterlife Pharma Inc income statement history.

About Better Home and Finance Holding Co Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.